Literature DB >> 27227363

Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.

Genaro R Villa1,2, Paul S Mischel3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27227363     DOI: 10.1038/nn.4302

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

Review 3.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

4.  Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

5.  EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.

Authors:  Feng Liu; Gary C Hon; Genaro R Villa; Kristen M Turner; Shiro Ikegami; Huijun Yang; Zhen Ye; Bin Li; Samantha Kuan; Ah Young Lee; Ciro Zanca; Bowen Wei; Greg Lucey; David Jenkins; Wei Zhang; Cathy L Barr; Frank B Furnari; Timothy F Cloughesy; William H Yong; Timothy C Gahman; Andrew K Shiau; Webster K Cavenee; Bing Ren; Paul S Mischel
Journal:  Mol Cell       Date:  2015-10-08       Impact factor: 17.970

6.  Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.

Authors:  Arezu Jahani-Asl; Hang Yin; Vahab D Soleimani; Takrima Haque; H Artee Luchman; Natasha C Chang; Marie-Claude Sincennes; Sidharth V Puram; Andrew M Scott; Ian A J Lorimer; Theodore J Perkins; Keith L Ligon; Samuel Weiss; Michael A Rudnicki; Azad Bonni
Journal:  Nat Neurosci       Date:  2016-04-25       Impact factor: 24.884

7.  Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Authors:  Igor Vivanco; H Ian Robins; Daniel Rohle; Carl Campos; Christian Grommes; Phioanh Leia Nghiemphu; Sara Kubek; Barbara Oldrini; Milan G Chheda; Nicolas Yannuzzi; Hui Tao; Shaojun Zhu; Akio Iwanami; Daisuke Kuga; Julie Dang; Alicia Pedraza; Cameron W Brennan; Adriana Heguy; Linda M Liau; Frank Lieberman; W K Alfred Yung; Mark R Gilbert; David A Reardon; Jan Drappatz; Patrick Y Wen; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Howard A Fine; Steve Horvath; Nian Wu; Andrew B Lassman; Lisa M DeAngelis; William H Yong; John G Kuhn; Paul S Mischel; Minesh P Mehta; Timothy F Cloughesy; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2012-03-31       Impact factor: 39.397

8.  EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

Authors:  Qi-Wen Fan; Christine K Cheng; W Clay Gustafson; Elizabeth Charron; Petra Zipper; Robyn A Wong; Justin Chen; Jasmine Lau; Christiane Knobbe-Thomsen; Michael Weller; Natalia Jura; Guido Reifenberger; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

9.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

Review 10.  Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.

Authors:  Maria M Caffarel; Nicholas Coleman
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

View more
  5 in total

1.  EGFRvIII vaccine in glioblastoma-InACT-IVe or not ReACTive enough?

Authors:  Michael Platten
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 2.  Role of Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme.

Authors:  Vishal Jindal
Journal:  Mol Neurobiol       Date:  2018-03-09       Impact factor: 5.590

Review 3.  Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma.

Authors:  Pei-Pei Ren; Ming Li; Tian-Fang Li; Shuang-Yin Han
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading.

Authors:  Maria R Jubran; Ariel M Rubinstein; Irina Cojocari; Ibukun Adesoji Adejumobi; Maxim Mogilevsky; Sama Tibi; Ronit V Sionov; Maïté Verreault; Ahmed Idbaih; Rotem Karni; Nataly Kravchenko-Balasha
Journal:  Oncogenesis       Date:  2020-02-05       Impact factor: 7.485

5.  Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.

Authors:  Eduardo Reátegui; Kristan E van der Vos; Charles P Lai; Mahnaz Zeinali; Nadia A Atai; Berent Aldikacti; Frederick P Floyd; Aimal H Khankhel; Vishal Thapar; Fred H Hochberg; Lecia V Sequist; Brian V Nahed; Bob S Carter; Mehmet Toner; Leonora Balaj; David T Ting; Xandra O Breakefield; Shannon L Stott
Journal:  Nat Commun       Date:  2018-01-12       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.